320 related articles for article (PubMed ID: 21924337)
1. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y
J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337
[TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action.
Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
4. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression.
Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT
J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903
[TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits.
Liu Y; Zhang HG; Jia Y; Li XH
Biol Pharm Bull; 2010; 33(8):1324-30. PubMed ID: 20686226
[TBL] [Abstract][Full Text] [Related]
6. Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells.
Li XD; Wang JS; Chang B; Chen B; Guo C; Hou GQ; Huang DY; Du SX
J Ethnopharmacol; 2011 Mar; 134(2):268-74. PubMed ID: 21167926
[TBL] [Abstract][Full Text] [Related]
7. Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes.
Chen S; Liu J; Liu X; Fu Y; Zhang M; Lin Q; Zhu J; Mai L; Shan Z; Yu X; Yang M; Lin S
J Ethnopharmacol; 2011 Sep; 137(1):263-70. PubMed ID: 21619920
[TBL] [Abstract][Full Text] [Related]
8. Effects of Panax notoginseng saponins on proliferation and apoptosis of vascular smooth muscle cells.
Xu L; Liu JT; Liu N; Lu PP; Pang XM
J Ethnopharmacol; 2011 Sep; 137(1):226-30. PubMed ID: 21619919
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice.
Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C
Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656
[TBL] [Abstract][Full Text] [Related]
10. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
[TBL] [Abstract][Full Text] [Related]
12. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway.
Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
Liu L; Shi R; Shi Q; Cheng Y; Huo Y
Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
[TBL] [Abstract][Full Text] [Related]
14.
Zhao Y; Zheng J; Yu Y; Wang L
Biomed Res Int; 2018; 2018():9239354. PubMed ID: 30151392
[No Abstract] [Full Text] [Related]
15. Panax notoginseng saponins suppress lipopolysaccharide-induced barrier disruption and monocyte adhesion on bEnd.3 cells via the opposite modulation of Nrf2 antioxidant and NF-κB inflammatory pathways.
Hu S; Liu T; Wu Y; Yang W; Hu S; Sun Z; Li P; Du S
Phytother Res; 2019 Dec; 33(12):3163-3176. PubMed ID: 31468630
[TBL] [Abstract][Full Text] [Related]
16. Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats.
Rong L; Chen Y; He M; Zhou X
Respirology; 2009 Aug; 14(6):890-8. PubMed ID: 19659831
[TBL] [Abstract][Full Text] [Related]
17. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice.
Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J
Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987
[TBL] [Abstract][Full Text] [Related]
18. Effects of panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits.
Zhang J; Li Q; Shao Q; Song J; Zhou B; Shu P
J Cell Biochem; 2018 Nov; 119(10):8410-8418. PubMed ID: 29932250
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of altered TNF-alpha expression by macrophage and the modulatory effect of Panax notoginseng saponins in scald mice.
Wang Y; Peng D; Huang W; Zhou X; Liu J; Fang Y
Burns; 2006 Nov; 32(7):846-52. PubMed ID: 16814471
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Panax notoginseng saponins on vascular intima hyperplasia and PCNA expression in rat aorta after balloon angioplasty].
Wang J; Wu L; Zhang W; Deng C
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):735-9. PubMed ID: 19624018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
